menu search

Fed rate hikes peaking? top-ranked etfs to buy

Stock markets rallied on Nov 1, 2023 in response to two significant factors including the Fed's possibl...

November 2, 2023, 9:46 am

Should you buy plains all american (paa) ahead of earnings?

Plains All American (PAA) is seeing favorable earnings estimate revision activity and has a positive Za...

November 2, 2023, 9:46 am

Why restaurant brands (qsr) might surprise this earnings season

Restaurant Brands (QSR) is seeing favorable earnings estimate revision activity and has a positive Zack...

November 2, 2023, 9:46 am

Should you buy cinemark (cnk) ahead of earnings?

Cinemark (CNK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earning...

November 2, 2023, 9:46 am

Clorox posts surprise profit for 1q as it lowers full-year outlook following cyberattack

The Clorox Company (NYSE:CLX) shares added almost 8% in early trade as its fiscal first quarter financial results were not as negatively imp...

November 2, 2023, 9:41 am

Adamas one announces first delivery of lab-grown colorless diamonds

Adamas One Corp has reported the initial delivery of colorless diamonds in the D, E, and F color range.  The lab-grown diamond manuf...

November 2, 2023, 9:40 am

Eur/gbp technical: medium-term bullish basing as boe looms

Three key technical developments have suggested that the EUR/GBP cross pair has formed a potential medium-term bullish basing configuration since 23 A...

November 2, 2023, 9:31 am

Gbpusd tests key descending trendline

GBPUSD slightly higher today as market digests Fed meeting It tests again the July 14 aggressive descending trendline Momentum indicators remain muted...

November 2, 2023, 9:29 am

Gbp/usd forecast: pound sterling needs a hawkish boe to clear 1.2200

GBP/USD gathered bullish momentum and registered gains on Wednesday after dropping below 1.2100 earlier in the day. The pair continued to stretch high...

November 2, 2023, 9:29 am

Wti oil futures succumb to bearish pressures

WTI futures decline after rejection at 50-day SMA Found their feet around the 80.00 handle, forming potential double bottom Momentum indicators deep i...

November 2, 2023, 9:28 am

Talon metals signs agreement with us doe for $114.8m in bipartisan infrastructure law funding

Talon Metals Corp. (TSX:TLO, OTC:TLOFF) told investors it has signed a definitive agreement with the US Department of Energy (DOE) setting the terms, ...

November 2, 2023, 9:24 am

In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta ...

November 2, 2023, 9:17 am

Ftse 100 rallies ahead of boe rate decision

U.K. stocks advanced on Thursday as investors reacted to a slightly dovish stance from the Federal Rese...

November 2, 2023, 9:14 am

Gbp/jpy keeps the red around 183.00, defends 100-day sma support ahead of boe

GBP/JPY drifts lower for the second straight day, though the downside remains limited. Intervention fears boost the JPY and turn out to be a key f...

November 2, 2023, 9:14 am

Sidus space awarded multi-million-dollar contract for commercial lunar transportation

Sidus Space Inc (NASDAQ:SIDU) announced that it has been awarded a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contr...

November 2, 2023, 9:13 am

Nasdaq 100, dow jones, s&p 500 news: starbucks earnings could set early tone

As Nasdaq Composite investors eye corporate earnings, including Starbucks, markets exhibit an upbeat mood, shifting focus from Fed’s ...

November 2, 2023, 9:10 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Roku's q3 loss wider than expected, revenues increase y/y

ROKU's third-quarter 2023 results benefit from growing active accounts and streaming hours on The Roku ...

November 2, 2023, 9:01 am

Boj's main message is to maintain easy policy, even if their actions contradict - report

The report says that the BOJ is to continue a gradual exit from its ultra-loose monetary policy and may look to step up its plans some time next year....

November 2, 2023, 9:00 am


Search within

Pages Search Results: